Cardio Diagnostics Holdings, Inc. (CDIO) stock
CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW
$1.87−0.05 (-2.60%)
Close on Nov 12, 2026Market cap $5.53MP/E –Yield –
Cardio Diagnostics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cardio Diagnostics's enterprise value was $5.68M on Nov 11, 2026, against -$1.27M a year earlier. Over the last 5 years it ranged from -$8.10M to $33.09M, with a median of $6.48M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.68M | – |
| 2025 | Dec 31, 2025 | -$1.57M | -106.1% |
| 2024 | Dec 31, 2024 | $25.84M | -11.0% |
| 2023 | Dec 29, 2023 | $29.04M | – |
| 2022 | Dec 30, 2022 | -$7.94M | – |
See a number that looks wrong?